The drug metformin, a mainstay of diabetes care for 15 years, may have a new life as a cancer treatment. In a study in mice, low doses of the drug, combined with a widely used chemotherapy called doxorubicin, shrank breast-cancer tumours and prevented their recurrence more effectively than chemotherapy alone
Share this Story